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Background: Otitis media (OM) is one of the most common infections diagnosed in young 
children around the world. Approximately $4.0 billion is spent annually on healthcare costs 
related to OM. Studies have shown OM to be highly prevalent (near 100%) in individuals with 
orofacial clefts (OC). OCs are the most common craniofacial birth defect in the world with 
approximately one in 500 to 1000 live births being affected. The medical costs for corrective 
surgeries alone pose a significant public health problem. These two conditions combined create a 
significant burden on the health, quality of life, and socioeconomic well-being of those affected 
and their family members.  
The principal aim of this study is to investigate the frequency of OM in unaffected first-
degree relatives of affected cleft individuals compared to controls, and to investigate and 
compare the reported rate of OM in individuals affected with different types of clefts.  
Methods: The OC study of cleft lip and palate demographics and medical history 
questionnaire from the University of Pittsburgh 2009 was used to collect data for previous 
studies at 6 different study locations. Information collected via surveys was statistically analyzed 
using chi-squared analysis. Multiple comparisons were made between affected probands 
depending on cleft types, unaffected first-degree relatives, and controls.   
Seth M. Weinberg, Ph.D. 
OTITIS MEDIA IN NONSYNDROMIC OROFACIAL CLEFT FAMILIES 
Teresa A. Ruegg, M.S. 
University of Pittsburgh, 2014 
ABSTRACT
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Results: The likelihood of having chronic OM was increased in those with palatal 
involvement 2-fold (RR = 2.28, 95% CI = 2.02-2.57) over the cleft lip population. No 
statistically significant pattern was found in the siblings and parents of probands with different 
cleft forms. All cleft forms demonstrated a higher frequency of OM over the control population. 
Interestingly, the cleft lip population also demonstrated a 3-fold (OR = 3.09, 95% CI = 1.95-
4.91) increased risk of OM over the control population, when previous studies provided evidence 
for no increase in this population. Siblings and parents failed to demonstrate statistically 
significant increases in OM compared to controls, and demonstrated a significantly reduced rate 
of OM than their affected relatives.  
Conclusion: This study confirms that the NSOC population has a higher prevalence of 
OM than in the general population, with an increase in prevalence of OM in the CL population 
not described in historical research. There is no increase in prevalence of OM in the first-degree 
relatives of the cleft population. 
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1.0  INTRODUCTION 
Approximately one in every 500 to 1000 live births is affected with an orofacial cleft (OC), 
making OC’s a relatively common birth defect (Fogh-Andersen 1942; Woolf et al. 1963; 1964; 
Wyszynski et al. 1996; Croen et al. 1998; Weinberg, 2007a; 2007b; Dixon et al. 2011; Kohli et 
al. 2011; Yaqoob et al. 2013). Worldwide, orofacial clefts are the most common craniofacial 
birth defect. The significant number of affected individuals as well as the substantial cost to 
repair OCs represents a major public health problem. The extensive surgeries required to repair 
the cleft place a substantial financial burden on the health care system (Weinberg, 2007a). 
Multiple surgeries are required depending on the severity of the cleft and the extent of the 
craniofacial abnormalities. The surgeries are expensive, painful, time consuming, and 
emotionally draining for families and have the potential to create rifts within the family unit. 
Additionally, these children are susceptible to having feeding complications, require hearing and 
speech therapy, orthodontic treatment, otolaryngology treatment, psychosocial counseling, and 
treatment for recurring ear infections (Nemana et al. 1992; Neiswanger et al. 2002; Weinberg, 
2006; 2007a; 2007b; Mossey et al. 2009; May, 2011). Neonates with an OC have increased 
infant mortality and morbidity compared to unaffected children, especially for those in 
developing countries with limited care options for individuals with an OC (Dixon et al. 2011).  
The vast majority of OCs are isolated and are not present as part of a syndrome. Non-
syndromic orofacial clefts (NSOC) account for approximately 75% of affected cases, while 
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approximately 25% are considered syndromic (Weinberg, 2007a). While syndromic cleft cases 
are typically due to specific mutations or chromosomal abnormalities, identifying the genetic 
basis for NSOCs has been much more difficult due to the complex etiology (Woolf et al. 1963; 
Fraser 1970; Spirtz, 2001; Wyszynski et al. 1996; Weinberg, 2007a; Mossey, et al. 2009; Dixon 
et al. 2011; Kohli et al. 2012; Shkoukani et al, 2013; Yaqoob et al. 2013). For families with an 
affected child, the chance of recurrence is often a major concern. Doctors and genetic counselors 
quote an empirical recurrence risk depending on the type of cleft and the family history. 
However, research has shown that the general population recurrence risk may not apply to all 
families (Weinberg, 2007a). For some families a more accurate risk number can be determined 
based on specific phenotypic craniofacial abnormalities shared within families. Previous studies 
suggest that those with an NSOC and their unaffected relatives have related physical 
characteristics, which differ from the general population (Weinberg, et al. 2006; 2007a; 2007b; 
Marazita, 2012).  
OCs – especially those where the hard palate is affected, have a much greater risk of 
chronic otitis media (Paradise, 1969; Bluestone, 1971; 1972a; 1972b; 1975; 2004; Doyle et al. 
1980; Shibahara et al. 1988Matsune et al. 1991a; 1991b; Daly et al. 2000; Sheahan et al. 2003; 
Lieberthal, 2006; Flynn et al. 2009; Sheer et al. 2010;). Otitis media is defined as an infection in 
the middle ear and is a common occurrence in the general population. The majority of children 
have at least one episode of otitis media, with 50-85% of children affected before the age of three 
(Doyle et al. 1980; Daly et al. 2000; Flynn et al. 2009). Approximately 10-20% of children under 
the age of one have recurrent otitis media, defined as three or more episodes, and nearly 40% of 
older children have six or more otitis media episodes in their lifetime (Sheahan, 2003). With over 
2.2 million cases of otitis media diagnosed each year in the United States and costing $4.0 billion 
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annually, otitis media is a major public health concern (Kemaloglu et al. 2000; Sheahan, 2003). 
While children without OCs may require eustachian tube placement if the infection persists or 
occurs multiple times in a short period of time, nearly all children with isolated cleft palate (CP) 
have chronic otitis media and require eustachian tube placement. Children without a surgical 
repair of the palate can develop otitis media well into adulthood. Once a child has a repaired 
palate, their risk of developing chronic otitis media drops to that of the general population 
(Paradise, 1969; Bluestone, 1971; 1972a; 1972b; 1975; 2004; Doyle et al. 1980; Shibahara et al. 
1988; Matsune et al. 1991a; 1991b; Daly et al. 2000; Sheahan et al. 2003; Lieberthal, 2006; 
Flynn et al. 2009; Sheer et al. 2010).  
The high incidence of otitis media in those affected with OCs can be explained by the 
anatomical disruption of the palatal shelves, which subsequently disrupts the position and 
orientation of the eustachian tubes thereby inhibiting proper drainage (Bluestone, 1971; 1975; 
Shibahara et al. 1988; Siegel et al. 1988; Sadler-Kimes et al. 1989; Takasaki et al. 2000; Sheahan 
et al. 2003; Bluestone, 2004). Although a visible cleft may not be present, there is evidence that 
the palatal configuration in the parents and siblings of OC cases may also be abnormal. Such 
minor abnormalities are hypothesized to represent a sub-clinical phenotypic manifestation of an 
underlying genetic predisposition (Allen et al. 2014). Because the palate may be abnormal, these 
unaffected relatives may be at elevated risk for eustachian tube dysfunction. To date, however, 
there are no data on the incidence of otitis media in the ostensibly unaffected family members of 
individuals with OCs. The present study will explore the occurrence of otitis media in a sample 
of NSOC families, focusing on both affected individuals with different types of clefts and their 
unaffected parents and siblings.  
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2.0  OROFACIAL CLEFTING 
2.1 CLASSIFICATION AND PHENOTYPIC VARIABILITY 
The classification of OCs has been proposed in a variety of different ways. There are several 
classification schemes based on anatomical location (Fogh-Andersen, 1942; Millard, 1976; 
Weinberg, 2007a). Clefts can be limited to the primary palate, which includes the lip and 
alveolus (CL or CL/A). There can also be clefts involving both the primary and secondary palate 
(CLP) and clefts involving only structures posterior to the incisive suture, which includes the soft 
palate (CP). When any form of clefting involves the primary palate, it can be either unilateral or 
bilateral. 
Clefts can also be classified according to etiology. OCs can be part of a syndrome caused 
by single-gene mutations, chromosomal abnormalities, or teratogen exposures. However, the 
majority of OCs are nonsyndromic; they do not occur as part of a recognized syndrome and are 
present in the absence of additional malformations. NSOCs do not follow a simple (Mendelian) 
inheritance pattern and are considered complex genetic traits. Based on recurrence data, 
nonsyndromic CL and CLP are typically considered etiologically similar and part of the same 
phenotypic spectrum; together they are referred to as cleft lip with or without cleft palate (CL/P). 
Nonsyndromic CP is considered etiologically distinct. Murray (2002) reports that over 70% of all 
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CL/P cases are nonsyndromic, while approximately 50% of CP cases are considered 
nonsyndromic. This investigation focuses exclusively on nonsyndromic clefting (CL, CP, CLP). 
2.2 EMBRYOLOGY 
Facial development occurs between the fourth and eighth week post-conception (Yoon, 2000; 
Senders, 2003; Jiang, 2006). During the fourth week of development, there are several distinct 
facial prominences surrounding the primitive oral cavity. At the end of the fourth week of 
development two ectodermal thickenings (nasal placodes) appear on the frontonasal process, 
these are the precursors of the olfactory epithelium. During the fifth week, the olfactory network 
continues to develop with lateral nasal and medial nasal swellings, which surround the nasal 
placodes on the frontonasal process. While the lateral and medial nasal swellings grow forward, 
the nasal placodes invaginate providing the first step in development of the nasal cavities. 
Concurrently, paired maxillary processes develop from the mandibular prominences enlarging 
and growing (ventrally and medially) to surround the future oral cavity (Figure 1). Growing 
rapidly, the maxillary processes meet with the lateral nasal process forming the nasal fin. The 
breakdown of the nasal fin is required for the two nasal prominences to fuse with the medial 
nasal prominences. Jiang (2006) suggests that the fusion process involves restricted apoptosis 
and/or epithelial-mesenchymal transformation. In the sixth week of development the medial 
nasal processes start to form a primitive nasal septum and primary palate. These structures 
eventually form into the philtrum and complete upper lip late in the seventh week. The palatal 
shelves elevate and fuse forming the secondary palate as well during the seventh week. By the 
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beginning of the eighth week of development, the basic face is formed (Diewert et al. 1993a, 
1993b, 2002; Diewert et al. 1993; Avery, 1994; Som et al. 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The skeletal and other connective tissues of the face are derived from neural crest derived 
mesenchyme (Grahm, 2003), while the facial musculature is derived from the cranial paraxial 
mesoderm (Noden et al. 2006). The epithelium of the face is derived from the surface covering 
the facial prominences, the ectoderm. Development of the face occurs when key genes are 
activated signaling the different tissues to interact (e.g. Bmp4) (Francis-West et al. 1998; 
Richman et al. 2003; Jiang, 2006; Parada et al. 2012). For the face to form properly, the process 
described above requires careful arrangement of multiple proteins to mediate the tasks of the 
bilateral symmetric cell migration, differentiation, growth, and apoptosis (May, 2011). An error 
in any part of this process can lead to partial or complete failure of the paired structures causing a 
cleft. There are a variety of cleft configurations described to date, ranging from a slight cleft of 
Figure 1: Face configuration on day 45 of development.  
          A. Frontonasal prominence; B. Right Maxillary Prominence;  
          C. Left maxillary Prominence; D. Left Mandibular Prominence 
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the lip to a complete bilateral cleft of the lip and palate (Figure 2). Each cleft type is dependent 
on the protein error, which causes a specific part of the process to be affected (Cohen, 2006; 
Mossey et al. 2009; May, 2011). 
 
 
Figure 2: The Variety of Cleft Configurations (non-syndromic).  
A. Incomplete Cleft Lip; B. Unilateral Complete Cleft Lip; C. Complete Bilateral Cleft Lip; D. Cleft Palate 
Only; E. Unilateral Cleft Lip and Palate; F. Bilateral Cleft Lip and Palate. * 
2.3 EPIDEMIOLGY 
Orofacial clefts are among the most common birth defects worldwide. Approximately one in 
every 500 to 1000 live births is affected (Fogh-Andersen, 1942; Woolf et al. 1963; 1964; 
Wyszynski et al., 1996; Croen et al. 1998; Weinberg, 2007a; 2007b; Dixon et al. 2011; Kohli et 
al. 2011; Yaqoob et al, 2013). In general, CL/P occurs more frequently than CP. The frequency 
of CLP also differs by sex with a 2:1 male to female ratio for clefts involving the lip and a 1:2 
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male to female ratio for cleft palate only. Furthermore, there is a 2:1 ratio of left to right sided 
clefts in unilateral cases (Dixon et al. 2011).  
There is also ethnic variation in incidence. Croen et al. (1998) performed a study in 
California with 2,000 individuals with NSOCs of different ethnic populations demonstrating an 
incidence of 1.5-2 for every 1,000 live births. The incidence of clefting varied by population: 
White, Native American, African American, Hispanics, Japanese, and Chinese. The prevalence 
of CL/P was highest in Native Americans, then Whites, Japanese, Chinese, and African 
Americans. A similar ranking was found among the CP patients with Native American’s again 
having the highest rate, followed by Whites, Hispanics, and African Americans. This study 
shows that although clefting is found worldwide, there are different ethnicities that show a higher 
incidence, which could suggest a genetic cause.   
2.4 ETIOLOGY 
CL/P and CP are complex genetic traits. They are often referred to as multifactorial, meaning 
there are multiple genetic and non-genetic (environmental) factors that can contribute to cleft 
susceptibility. Multifactorial diseases, or in this case birth defects, are complex due to the lack of 
a simple inheritance pattern. There is no defining Mendelian inheritance pattern (e.g., autosomal 
recessive or autosomal dominant) for complex disease traits, making it more difficult to predict 
the probability of passing on such a trait to the next generation. Multifactorial traits possess the 
same complexities as Mendelian diseases, such as: heterogeneity, variable expressivity, 
phenocopies, and reduced penetrance. Added to this are the complications of additive and/or 
multiplicative gene-gene and gene-environment interactions. Together, all of these factors make 
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the etiologies of complex traits difficult to determine, and since many diseases are complex, it is 
challenging to find causes for some of our most common health conditions (Weinberg, 2007a; 
Yaqoob et al. 2013). 
The work by Fogh-Andersen (1942) thoroughly summarized hereditary cases of clefts in 
the 1920-1940s. Some researchers suggested an autosomal dominant inheritance, other suggested 
recessive; some researchers determined the trait was sex-linked, while others showed incomplete 
dominant inheritance patterns within families. Furthermore, by studying these cases, Fogh-
Andersen was the first to distinguish between CL/P and CP, suggesting not only that most cases 
of CL/P were genetic, but that they were dominant sex-limiting to males. By the early 1960’s, 
multifactorial patterns of inheritance were being developed and were immediately applied to 
CL/P (Woolf et al. 1963; 1964; Fraser, 1970; 1976; Carter et al. 1982; Hu et al. 1982; Weinberg, 
2007a). By studying different models (e.g., multifactorial threshold theory, segregation analysis, 
goodness-to-fit approaches) it seemed that CL/P fit no distinct pattern, although there was 
evidence for every model, there was no exact fit (reviewed in Weinberg, 2007a). Families 
seemed to show a higher recurrence risk of producing a child with a cleft if a previous child was 
born with a cleft compared to the general population (Wyszynski et al. 1996). Therefore, familial 
patterns of recurrence were studied to determine the genetic basis of clefting (Weinberg, 2007a). 
These studies showed the recurrence risk for first-degree relatives is around 4% - 40 times 
greater than the general population - with the recurrence increasing as more individuals in a 
family are affected (Mitchell et al. 1993).  
Many years of research have scrutinized CL/P families for a definitive genetic cause. In 
that time there are a number of different genes known to cause orofacial cleft syndromes, such 
as: Kabuki syndrome, Oral-facial-digital syndrome, chromosomal aberrations (such as 
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translocations) (Yagoob, 2013), Apert syndrome, Van der Woude syndrome, CL/P ectodermal 
dysplasia syndrome, Crouzon syndrome, Pierre Robin syndrome, Treacher Collins syndrome,  
(Kohli et al. 2012), and many more. However, a definitive genetic cause for the vast majority of 
NSOCs has not been identified. Candidate genes or loci have been the major focus for research 
in this discipline. Kohli et al. (2012), review the candidate genes found to date thought to be 
linked to NSOCs. Transforming growth factor-alpha (TGFA) is one such gene that has 
demonstrated a mixture of results, suggesting that certain mutations in this gene could be 
etiological to clefts, while others suggest that certain variants (TaqI C2 allele) together with 
maternal smoking and/or lack of prenatal vitamins in the first trimester increases the risk for a 
fetus to develop a cleft. The Drosophila msx homeobox homolog-1 (MSX1) gene was first found 
to cause autosomal dominant tooth agenesis and concurrent presence of CL/P. It has been 
suggested that MSX1 mutations contribute to approximately 2% of all nonsyndromic CL/P 
(Jezewski et al. 2003). The enzyme 5,10-Methylenetetrahydrofolate reductase (MTHFR) is an 
important catalyst in the folate metabolism pathway. The MTHFR C677T single-nucleotide 
polymorphism (SNP) is a risk factor for neural tube defects and an increased risk for CLP (up to 
10 times the general population risk). The gene transforming growth factor-beta-3 (TGFB3) is 
important in the adhesion of the opposing palatal shelves during face formation. The IVS5+104 
A>G SNP was recently found to increase the risk of CL/P in the Korean population by as much 
as 16 times. There are many other candidate genes being researched, a review of all of these 
genes is beyond the scope of this paper. 
 In addition to genetic causes, there are wide varieties of environmental factors causing 
CL/P. Several of these are related to teratogenic and maternal health factors. A teratogen is 
defined as any substance that can cause malformations in a developing fetus (Wilson et al. 1977). 
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There are several drugs known to cause a teratogenic effect (causing a cleft) when taken during 
the first eight weeks of pregnancy, such as: hydantoin, sodium valproate, trimethadion, 
tranquilizers (Yaqoob et al. 2013), anti-convulsants (Abrishamchian et al. 1994), 
benzodiazepines (Dolovich et al. 1998), folate antagonists (Hernandez-Diaz et al. 2000), 
maternal smoking (Wyszynski et al. 1997), and alcohol (Munger et al. 1996; Kohliet al. 2012; 
Yaqoob et al. 2013). Each of these drugs has an effect on the developing fetus, typically in a 
dose-dependent manner (Shaw et al. 1999; Chung et al. 2000). Other teratogens such as toxins 
(organic solvents, and pesticides), as well as maternal infections associated with fever may be 
related to isolated clefts. Factors associated with maternal health have also been shown to play a 
role in cleft development (Hayes, 2002; Shashi et al. 2002; Weinberg, 2007a; Yaqoob et al. 
2013). In animal studies, deficiencies in vitamins A, various B vitamins, and folic acid, have 
consistently been shown to result in OCs (Munger, 2002). Mothers suffering from diabetes 
mellitus or phenylketonuria are at higher risk of having a child with an OC (Weinberg, 2007a; 
Kohli et al. 2012; Yaqoob et al. 2013). 
2.5 EXPANDED PHENOTYPE CONCEPT 
OCs exhibit highly variable phenotypic expression. The clinical spectrum of clefting ranges from 
bilateral complete clefts extending all the way through the soft palate to microforms that appear 
as little more than a notch or scar on the upper lip (Weinberg et al. 2007b). In recent years, there 
has been renewed attention on how the OC phenotype is defined (Weinberg et al. 2006; Dixon et 
al., 2011). There is now a recognition that the phenotypic spectrum of clefts extends beyond 
“clinical” or “overt” manifestations. Subclinical expressions of the trait or of the same 
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underlying genetic risk factors have now been documented in cleft samples; these include altered 
brain morphology (Nopoulos et al. 2002; Weinberg et al. 2013), minor dental anomalies 
(Weinberg, et al. 2006; Shkoukani, et al. 2012), increased morphological asymmetry and/or 
altered laterality (Weinberg et al. 2006; Marazita, 2012), minor vertebral anomalies (Weinberg et 
al. 2006; Pisek et al. 2013), and dermatoglyphic abnormalities (Weinberg et al. 2006; Marazita,  
2012). These expressions are typically subtle and may present with no functional deficit, eluding 
formal clinical recognition and characterization. Some are quantitative, requiring sophisticated 
phenotyping strategies. These additional phenotypic expressions can inform investigations into 
the etiology of OCs. For example, patterns of expression or co-expression of these subclinical 
traits may reveal distinct etiological subtypes of clefting. 
Importantly, subclinical cleft phenotypes have also been documented in the unaffected 
(i.e., non-cleft) relatives of affected individuals (Weinberg et al. 2006). Beginning in the 1960’s 
and stimulated by the emergence of multifactorial inheritance models, numerous reports have 
documented numerous subtle morphological differences statistically over-represented in the 
parents and siblings of cleft affected individuals compared to the general population. Some of 
these features are true micro-expressions of the trait, such as occult defects of the upper lip 
musculature only detectable on ultrasound (Weinberg et al. 2007b) or subtle speech 
abnormalities (Shkoukani et al. 2013). Others are best conceptualized as associated risk 
phenotypes, such as differences in craniofacial and dental morphology (reviewed in Weinberg et 
al. 2006). In either case, the presence of these traits in family members is believed to represent a 
mild expression of the underlying genetic susceptibility. 
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The expanded phenotype concept provides the conceptual framework for the present 
study. The current focus will be on the phenotype of otitis media – its co-occurrence with 
different forms of clefting and its presence in unaffected family members. 
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3.0  CLEFTING AND OTITIS MEDIA 
3.1 OVERVIEW OF OTITIS MEDIA 
It is estimated that the United States spends over $5 billion in healthcare for otitis media in 
children (Gould et al., 2010; Allen et al. 2014). Over 90% of children up to age 5 have 
experienced at least one occurrence of otitis media (Daly and Giebink, 2000; Bluestone, 2004; 
Lieberthal, 2006; Allen et al. 2014). However, otitis media may be under reported because the 
only way to establish a diagnosis with any certainty is using the pneumatic otoscope with 
visualization of the tympanic membrane with identification of a middle-ear effusion and 
inflammatory changes (Bluestone, 2004; Lieberthal, 2006). Those of a lower socioeconomic 
status may not have access to the healthcare system; therefore, the otitis media in these children 
may resolve on its own without medical intervention (Daly et al. 2000). 
There are many different causes of otitis media infections. It is well known that the 
younger a child is, the higher the risk of developing an ear infection. The earlier one develops 
their first infection, the higher the risk of developing subsequent infections and chronic otitis 
media. As a child grows and develops, the angle and width of the eustachian tubes change, 
reducing the chances of developing otitis media [Figure 3] (Daly et al. 2000). Environmental 
factors also play a key role in the development of otitis media. Childcare attendance and 
exposure to young affected children (even siblings) greatly increases the risk for otitis media and 
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the requirement of tube placement. One study established a 2.5-fold risk of otitis media in 
children attending childcare outside the home (Uhari et al. 1996). Further environmental factors 
include protective effects of breast feeding when done for up to 3-6 months (with a 13% 
reduction in otitis media), and a detrimental effect of smoking with a 1.2 to 1.7 increase in 
incidence (Uhari et al. 1996; Daly et al. 2000; Bluestone, 2006). Furthermore, Daly et al. (2000), 
review a number of studies suggesting an increased otitis media risk in infants with very low 
birth weight, preterm birth, or intrauterine growth retardation. Structural abnormalities may also 
cause otitis media to occur. Since the growth and development of the anatomic region where the 
eustachian tube forms is associated with many other craniofacial abnormalities, it is evident that 
malformations in these craniofacial structures cause malformations of the eustachian tube 
(Kemaloglu et al. 2000). 
 
 
Figure 3: Eustachian tube differences in children and adults.  
The adult eustachian tube has a steeper angle than the child’s does. The steeper angle allows for easier drainage. The 
lack of drainage in a child’s ear is a major cause for otitis media. ** 
 
 16 
Like NSOC, otitis media is considered a multifactorial disease. Allen et al. (2014) 
reviewed research for the evidence for a genetic contribution to otitis media. Family studies have 
shown heritability estimates as high as 74% (Allen et al. 2014). These studies provided the 
framework for genome-wide studies in search of specific genes/regions associated with otitis 
media. The majority of these genes are involved in the inflammatory and immune response. So 
far, tentative associations have been reported with TLR4, MUC5B, SMAD2, SMAD4 (Allen et al. 
2014). Family-based designs for linkage studies with siblings (pairs and larger sibships), nuclear 
families, and extended pedigrees have provided further insights (Allen et al. 2014).  
Regardless of the cause, there are numerous treatment options available for those 
suffering from otitis media. Bluestone (2004), reviews, in depth, the different treatment options, 
which are beyond the scope of this thesis. Typically, treatment involves a course of systemic 
antibiotic (most commonly amoxicillin), which has shown to be effective not only as a treatment, 
but prophylactically as well. Surgical options have increased four-fold between 1970-1990 (Daly 
et al. 2000). Bluestone (2004) provides evidence for myringotomy and tympanostomy tube 
placement as providing the best treatment for those where surgical options are warranted. 
However, it seems that antibiotic in conjunction with surgical repair is the best option for most 
individuals. 
3.2 PREVALENCE OF OTITIS MEDIA IN CLEFTING 
Since 1969 when Paradise published his paper “Diagnosis and management of ear disease in 
cleft palate infants,” it has been accepted that otitis media is a common occurrence in cases of 
orofacial clefting (Paradise, 1969). He reported that cleft cases with a palatal involvement were 
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at much greater risk for developing otitis media compared to cases where the cleft involved only 
the lip. Paradise suggested that all infants with a cleft involving the secondary palate undergo 
routine otologic evaluation and have tubes placed as soon as possible to prevent otitis media. 
Many studies since Paradise have looked at the incidence of otitis media in relation to orofacial 
clefting. Sheahan et al. (2003) reported otitis media rate of 68% in CP patients, with a 45% 
recurrence rate, while there was an otitis media rate of 76% in CLP patients with a 46% 
recurrence risk. Suggesting a high rate of otitis media in patients affected with a cleft of the 
secondary palate; however, this rate is not nearly as high as Paradise’s ~100% incidence of OM 
reported in 1969. Bluestone (1971), found that 78% of infants with CP required tubes for the 
treatment of their otitis media, with a higher rate of otitis media without tube placement, stating 
the probability of all infants with cleft palate having middle ear disease at, or shortly after, birth. 
He later states the “universal incidence” of a middle-ear effusion in patients with unrepaired cleft 
palate (Bluestone, 2004). Further evidence suggests a 74.7% prevalence of otitis media in the 
unilateral CLP population (Flynn et al. 2009). Though not all of these percentages agree, there is 
one evident fact – there is a high prevalence of otitis media in those affected with a cleft of the 
secondary palate. 
Further studies on the topic by Bluestone (2004) suggest a reason for the high prevalence 
of otitis media in clefting. There are seven known abnormalities in the structure of the eustachian 
tube in cleft patients: shorter length of the tube, larger angle between cartilage and tensor veli 
palatine muscle, greater cartilage cell density, smaller ratio of lateral and medial laminae area of 
cartilage, less curvature of lumen, less elastin at hinge portion of cartilage, and less insertion 
ratio of tensor veli palatini to cartilage (Siegel et al. 1988; Shibahara et al. 1988; Sadler-Kimes et 
al. 1989; Sando and Takahashi, 1990; Matsune et al. 1991a; 1991b; Takasaki et al. 2000). These 
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differences help to illuminate the malformations of the eustachian tube caused by clefts, and the 
subsequent high rate of otitis media. The eustachian tube is part of a system of structures (palate, 
nasal cavities, nasopharynx, middle-ear, mastoid gas cell system). The function of the eustachian 
tube is to regulate the pressure in the middle ear, protect the middle ear from nasopharynx 
secretions, and drainage of middle-ear secretions into the nasopharynx. If the tube is too open or 
too closed, then there is abnormal pressure, which can cause an ear infection. Those with a cleft 
palate have a constricted eustachian tube, which impairs the normal drainage mechanism of the 
ear. If the tube cannot be opened to drain, then viruses or bacteria can remain within the tube 
causing major ear infections (Bluestone et al. 1972a; 1972b; 1975; 1980; 2004; Doyle et al. 
1980a; 1980b; 1982; 1986). 
Although the increased incidence of otitis media is well established in clefts involving the 
secondary palate (CP and CLP), far fewer studies have investigated clefts involving only the 
primary palate. Paradise (1969), initially reported a 96% rate for those with secondary palate 
involvement, while those with only CL reported a 17% rate of otitis media and controls having a 
20% rate of otitis media. It is interesting that his results showed that the rate of otitis media was 
actually less than in the control population, but he did have a small sample size of 12 CL 
probands. Sheahan (2003) corroborates Paradise’s data with a 16% rate of otitis media in their 
CL population compared to the 68% and 76% reported in their CP and CLP population, 
respectively. The highest rate of otitis media reported is Deelder et al. (2011); they found that 
33% of CL cases in their study reported an episode of otitis media. These results suggest that, 
while the rate of infection is much lower than for clefts involving the secondary palate, there is at 
least a subset of CL cases where the palatal and/or eustachian tube anatomy may be 
compromised and are therefore susceptible to otitis media. Such findings could affect how CL 
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cases are classified, with implications for treatment, recurrence estimation, and gene 
identification. 
3.3 OTITIS MEDIA AS A POTENTIAL MARKER FOR CLEFT RISK 
The expanded OC phenotype concept was introduced in section 2.5. Using the same rationale, it 
may be plausible to consider isolated otitis media as a subclinical expression of orofacial 
clefting, particularly when it occurs in the non-cleft relatives of affected individuals. There is 
additional anatomical evidence to justify this hypothesis. As reported by Kemaloglu et al. (2000) 
the development of the eustachian tube is closely associated with the development of the cranial 
base and nasomaxillary complex, including the hard palate and associated structures. Numerous 
studies report mild craniofacial changes in the unaffected family members of cleft probands 
compared with controls (Weinberg et al. 2007a). Several studies have specifically noted subtle 
abnormalities in the palatal configuration and cranial base of these unaffected relatives 
(Weinberg et al. 2007a). Such changes are likely to impact the orientation, structure and 
subsequent function of the eustachian tubes. To date no study has investigated the occurrence of 
otitis media in the unaffected family members of cleft cases. Excessive otitis media in this 
population would provide the first line of evidence that the trait might be indicative of an 
underlying genetic risk in the absence of an overt cleft. 
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4.0  PURPOSE OF THE PRESENT STUDY 
The aims of the present study are twofold: (1) to investigate the frequency with which otitis 
media occurs in the unaffected relatives (siblings and parents) from cleft families compared to 
both controls and affected cases; and (2) to investigate and compare the reported rate of otitis 
media in individuals affected with different types of clefts.  
Our general working hypothesis is that unaffected relatives from NSOC families will 
display a higher frequency of otitis media compared to controls with no prior history of clefting; 
this is predicted for all cleft types. It is further predicted that relatives of individuals with clefts 
involving the secondary palate (CP and CLP) will exhibit a higher occurrence compared to the 
relatives of CL individuals. Moreover, within cleft-affected cases, it is predicted that the rate of 
otitis media in CL individuals will be higher than controls but lower than in CP or CLP cases. 
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5.0  MATERIALS AND METHODS 
5.1 SAMPLE RECRUITMENT 
Subjects for this study were recruited at six separate data collection sites; this included five US 
sites (Pittsburgh, Texas, Iowa, Colorado, and St Louis) and one international site (Budapest, 
Hungary). All subjects were recruited as part of a larger genetic and phenotypic study 
coordinated by the Center for Craniofacial and Dental Genetics at the University of Pittsburgh. 
Probands and families were identified through a combination of targeted advertisements, word-
of-mouth, active recruitment at craniofacial centers, and various research registries and 
databases. 
This study consisted of three groups based on the type of cleft present in the proband: 
cleft lip only, cleft palate only, and cleft lip and palate. Each group was comprised of probands 
(affected cases), the proband’s unaffected parents, and the proband’s unaffected sibling(s). 
Affected siblings and parents were excluded from this study. Families with a known syndromic 
form of clefting were also excluded. Unaffected controls with no prior history of clefting in their 
family were also recruited at several of the aforementioned sites (Pittsburgh, Iowa, St. Louis and 
Hungary). 
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5.2 DATA COLLECTION PROCEDURE 
All recruitment and data collection procedures were conducted with the prior approval of the 
University of Pittsburgh Institutional Review Board (IRB) number 0405013 and additional local 
IRBs. Informed consent was obtained for each subject in the appropriate language prior to any 
data collection. Foreign and domestic data collection sites had slight differences in the 
questionnaire used. However, for the purposes of this study the questionnaire sections were 
designed in the same manner. The questionnaires were filled out by dedicated study staff at each 
site in an interview format. The answers were self-reported by family members or evident from 
the proband. 
5.2.1 Cleft Status 
Information on cleft status was obtained via a questionnaire. Proband cleft information was 
either self-evident or reported by family members. Medical history information such as specific 
cleft type in the proband and family members were verified at time of assessment as well. The 
LAHSHAL code was used to classify cleft phenotype (Kriens, 1989); this code was designed to 
provide researchers with a quick reference of cleft location (unilateral vs. bilateral; left vs. right) 
and type of defect (complete vs. incomplete; submucus, palatal, vs lip involvement). 
5.2.2 Otitis Media Status 
Otitis media information was self-reported by either the subject or the subject’s immediate 
family member. A questionnaire was used to collect multiple points of medical information for 
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each subject. Otitis media questions included: if an ear infection had been diagnosed, age of ear 
infections, ear infection medications, if ear tubes had been placed, age first ear tubes placed 
(section to mark months or years for the age), and ear infections in family. Due to inconsistencies 
between the sites, exclusions had to be made as well as extrapolations of the data provided (see 
section 5.3 below). 
5.2.3 Demographic Information 
Basic demographic information such as age, sex, race, and ethnicity were obtained for each 
subject (proband and family members) at the time of assessment. 
5.3 PARTICIPANT CRITERIA 
Since this project was part of a much larger study, several considerations had to be taken into 
account in order to determine the final dataset and evaluate the relationship between orofacial 
clefting and otitis media. Several of these considerations are outlined below. 
5.3.1 Inclusion/ Exclusion Criteria 
In order for the proband, and therefore family, be included in this study, subjects: (1) had a 
personal history of non-syndromic (isolated) cleft lip, cleft palate, or cleft lip and palate, (2) had 
no history of facial or head trauma, (3) could not have a family history of syndromic orofacial 
clefts, and (4) had data for cleft type and ear infection. For siblings and parents, to be included in 
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this study: (1) they must be unaffected (i.e. no OC), (2) in the case of more than two siblings the 
unaffected male and female closest in age to the proband were selected for study, and (3) data for 
ear infection must be present. 
5.3.2 Cleft Family Group Determination 
Family data was sorted into the four groups listed above (CL, CP, CLP, Control) based on the 
clinical diagnosis of OC in the proband. In some cases family members of the proband (i.e.: 
parent and/or sibling) were affected with a different OC. In these cases, only the phenotype of 
the proband was taken into account to determine family group for this study. Therefore, if the 
proband had a CLP and a parent or sibling had a CP, the family group designation was CLP.  
5.3.3 Extrapolations 
Occasionally otitis media status for subjects needed to be extrapolated from additional 
questionnaire data. For example, a subject might not have indicated otitis media, but did indicate 
that they had tubes placed or provided evidence that they had taken medications for ear 
infections. In these cases, the subject was marked positive for otitis media. 
5.4 SAMPLE CHARACTERISTICS 
Otitis media information was available for a total of 2344 subjects from the six data collection 
sites. Data from 1751 cleft probands and their family members were included (Hungary, n = 672; 
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Texas n = 345; Iowa n = 555, Colorado, n = 62; Pittsburgh, n = 620; and St Louis, n = 91). A 
total of 593 control subjects were available for comparison. Controls were collected from the 
following sites: Hungary, n = 213; Iowa, n = 155; Pittsburgh, n = 188; and St. Louis, n = 37. 
Table 1 shows the complete sample broken down by group and sex.  
 
Table 1: Sample size and mean age of groups represented in the present study. 
 CP CLP CL Controls 
 N Age N Age N Age N Age 
Affected Cases 
Combined 
Male 
Female 
 
87 
45 
42 
 
7.59 
7.42 
7.78 
 
323 
204 
119 
 
10.60 
9.95 
11.72 
 
114 
63 
51 
 
9.53 
7.91 
11.49 
 
593 
245 
348 
 
28.11 
26.55 
29.21 
Siblings 
Combined 
Brothers 
Sisters 
 
56 
21 
35 
 
8.79 
7.43 
9.60 
 
273 
127 
146 
 
10.82 
10.48 
11.12 
 
87 
48 
39 
 
10.23 
9.33 
11.30 
 
 
 
 
Parents 
Combined 
Fathers 
Mothers 
 
123 
52 
71 
 
37.66 
39.59 
36.23 
 
505 
213 
292 
 
38.73 
40.51 
37.44 
 
183 
77 
106 
 
37.50 
38.19 
36.99 
 
 
 
 
5.5 DATA ANALYSIS 
5.5.1 Statistical Analysis 
Frequencies of otitis media were calculated and compared across group using Chi-square or 
Fisher’s exact tests, as appropriate. Table 2 was created from initial count data and shows the 
frequency and proportion of subjects by group and sex with otitis media. A total of 81 univariate 
tests were run; adjusted for type 1 error due to multiple testing, the threshold for statistical 
significance was set at 0.0006.  
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Table 2: Frequency and proportion of reported otitis media by group. 
 CP CLP CL Controls 
Affected Cases 
Combined 
Male 
Female 
 
65/87 (74.7%) 
33/45 (73.3%) 
32/42 (79.2%) 
 
230/323 (71.2%) 
158/204 (77.5%) 
72/119 (60.5%) 
 
36/114 (31.6%) 
21/63 (33.3%) 
15/51 (29.4%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
Siblings 
Combined 
Brothers 
Sisters 
 
3/56 (5.4%) 
1/21 (4.8%) 
2/35 (5.7%) 
 
41/273 (15%) 
16/127 (12.6%) 
25/146 (17.1%) 
 
15/87 (17.2%) 
12/48 (25.0%) 
3/39 (7.7%) 
 
 
 
 
Parents 
Combined 
Fathers 
Mothers 
 
8/123 (6.5%) 
4/52 (7.7%) 
4/71 (5.6%) 
 
61/505 (12.1%) 
15/213 (7.0%) 
46/292 (15.8%) 
 
25/183 (13.7%) 
9/77 (11.7%) 
16/106 (15.1%) 
 
 
 
 
 
6.0  RESULTS 
6.1 COMPARING CLEFT CASES AND RELATIVES ACROSS CLEFT TYPES 
Individuals with a cleft involving the secondary palate (CP, CLP, or both combined) 
demonstrated a significantly higher frequency of otitis media compared to cases with only 
primary palatal involvement (cleft lip probands) (Table 3, Table 4, and Table 5). The likelihood 
of having otitis media was increased more than 2-fold (RR = 2.28, 95% CI = 2.02-2.57) in cases 
affected probands with CP/CLP over CL individuals (Table 5). This pattern was not sex specific. 
In addition, CP and CLP cases showed no differences in the frequency of otitis media (Table 6). 
In both the siblings and parents of probands with different forms of clefting, no clear 
pattern emerged. There was some evidence of increased otitis media in relatives of CL cases 
compared to relatives of CP cases (Table 3), but none of these differences reached statistical 
significance after adjusting for multiple testing. Likewise, no significant differences were noted 
when comparing the relatives (parents or siblings) between any of the cleft groups (Table 3, 
Table 4, Table 5 and Table 6).   
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Table 3: Comparing reported occurrence of otitis media in CP cases and family 
members to CL cases and family members. 
 CP CL  P RR 95% CI 
Affected Cases 
Combined 
Male 
Female 
 
65/87 (74.7%) 
33/45 (73.3%) 
32/42 (79.2%) 
 
36/114 (31.6%) 
21/63 (33.3%) 
15/51 (29.4%) 
 
36.72 
16.80 
20.16 
 
< 0.001 
< 0.001 
< 0.001 
 
2.37 
2.59 
2.20 
 
1.59-3.52 
1.45-4.64 
1.53-3.16 
Siblings 
Combined 
Brothers 
Sisters 
 
3/56 (5.4%) 
1/21 (4.8%) 
2/35 (5.7%) 
 
15/87 (17.2%) 
12/48 (25.0%) 
3/39 (7.7%) 
 
4.37 
3.91 
0.11 
 
0.037 
0.048 
0.740 
 
0.31 
0.74 
0.19 
 
0.11-0.89 
0.25-2.23 
0.15-0.24 
Parents 
Combined 
Fathers 
Mothers 
 
8/123 (6.5%) 
4/52 (7.7%) 
4/71 (5.6%) 
 
25/183 (13.7%) 
9/77 (11.7%) 
16/106 (15.1%) 
 
3.92 
0.55 
3.80 
 
0.048 
0.458 
0.051 
 
0.48 
0.37 
0.66 
 
0.26-0.88 
0.15-0.91 
0.44-0.98 
 
Table 4: Comparing reported occurrence of otitis media in CLP cases and family 
members to CL cases and family members. 
 CLP CL  P RR 95% CI 
Affected Cases 
Combined 
Male 
Female 
 
230/323 (71.2%) 
158/204 (77.5%) 
72/119 (60.5%) 
 
36/114 (31.6%) 
21/63 (33.3%) 
15/51 (29.4%) 
 
57.53 
29.37 
13.81 
 
< 0.001 
< 0.001 
< 0.001 
 
2.28 
2.06 
1.79 
 
1.96-2.64 
1.67-2.54 
1.45-2.21 
Siblings 
Combined 
Brothers 
Sisters 
 
41/273 (15%) 
16/127 (12.6%) 
25/146 (17.1%) 
 
15/87 (17.2%) 
12/48 (25.0%) 
3/39 (7.7%) 
 
0.25 
3.99 
2.13 
 
0.617 
0.046 
0.144 
 
0.87 
2.23 
0.50 
 
0.73-1.03 
1.91-2.60 
0.36-0.70 
Parents 
Combined 
Fathers 
Mothers 
 
61/505 (12.1%) 
15/213 (7.0%) 
46/292 (15.8%) 
 
25/183 (13.7%) 
9/77 (11.7%) 
16/106 (15.1%) 
 
0.31 
1.61 
0.03 
 
0.578 
0.205 
0.863 
 
0.88 
1.04 
0.60 
 
0.77-1.02 
0.89-1.23 
0.44-0.83 
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Table 5: Comparing reported occurrence of otitis media in NSOC cases and family 
members with any secondary palate involvement to those with lip involvement only. 
 CP and CLP CL  P RR 95% CI 
Affected Cases 
Combined 
Male 
Female 
 
295/410 (72.0%) 
191/249 (76.7%) 
104/161 (64.6%) 
 
36/114 (31.6%) 
21/63 (33.3%) 
15/51 (29.4%) 
 
62.49 
43.43 
19.47 
 
< 0.001 
< 0.001 
< 0.001 
 
2.28 
2.30 
2.20 
 
2.02-2.57 
1.94-2.73 
1.28-3.76 
Siblings 
Combined 
Brothers 
Sisters 
 
44/329 (13.4%) 
17/148 (11.5%) 
27/181 (14.9%) 
 
15/87 (17.2%) 
12/48 (25.0%) 
3/39 (7.7%) 
 
0.85 
5.25 
1.42 
 
0.357 
0.022 
0.233 
 
0.78 
0.46 
1.94 
 
0.66-0.91 
0.34-0.63 
1.69-2.23 
Parents 
Combined 
Fathers 
Mothers 
 
69/628 (11.0%) 
19/265 (7.2%) 
50/363 (13.8%) 
 
25/183 (13.7%) 
9/77 (11.7%) 
16/106 (15.1%) 
 
0.99 
1.62 
0.12 
 
0.320 
0.203 
0.729 
 
0.80 
0.61 
0.91 
 
0.71-0.91 
0.47-0.80 
0.79-1.06 
 
Table 6: Comparing reported occurrence of otitis media in CLP cases and family 
members to CP cases and family members. 
 CLP CP  P RR 95% CI 
Affected Cases 
Combined 
Male 
Female 
 
230/323 (71.2%) 
158/204 (77.5%) 
72/119 (60.5%) 
 
65/87 (74.7%) 
33/45 (73.3%) 
32/42 (79.2%) 
 
0.28 
0.35 
3.34 
 
0.597 
0.554 
0.068 
 
0.96 
0.79 
2.32 
 
0.86-1.07 
0.67-0.95 
1.89-2.86 
Siblings 
Combined 
Brothers 
Sisters 
 
41/273 (15%) 
16/127 (12.6%) 
25/146 (17.1%) 
 
3/56 (5.4%) 
1/21 (4.8%) 
2/35 (5.7%) 
 
3.74 
1.09 
2.40 
 
0.053 
0.297 
0.089 
 
2.80 
3.00 
2.65 
 
2.54-3.09 
2.62-3.43 
2.30-3.04 
Parents 
Combined 
Fathers 
Mothers 
 
61/505 (12.1%) 
15/213 (7.0%) 
46/292 (15.8%) 
 
8/123 (6.5%) 
4/52 (7.7%) 
4/71 (5.6%) 
 
3.14 
0.03 
4.92 
 
0.076 
0.863 
0.027 
 
1.86 
2.80 
0.92 
 
1.69-2.04 
2.53-3.09 
0.72-1.16 
6.2 COMPARING CLEFT CASES TO CONTROLS 
Individuals with a CP, CLP, and CL all demonstrated a higher frequency of otitis media (Table 
7) compared with controls. Female probands with CL were the only group where the increase 
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over controls did not reach the threshold for statistical significance after bonferonni correction. 
The odds of having otitis media with a CP was increased nearly 20-fold (OR = 19.80; 95% CI = 
11.54-34.0) for both sexes combined over the control population. Those with a CLP also 
displayed over 16-fold (OR = 16.57; 95% CI = 11.8-23.28) increased risk over controls and the 
CL population exhibited over a 3-fold (OR = 3.09; 95% CI = 1.95-4.91) increased risk.  
 
Table 7: Comparing reported occurrence of otitis media in NSOC cases to controls. 
 Cases Controls  P OR 95% CI 
CP 
Combined 
Male 
Female 
 
65/87 (74.7%) 
33/45 (73.3%) 
32/42 (79.2%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
 
174.97 
85.54 
89.49 
 
< 0.001 
< 0.001 
< 0.001 
 
19.80 
20.48 
20.00 
 
11.54-34.0 
9.52-44.06 
9.24-43.31 
CLP 
Combined 
Male 
Female 
 
230/323 (71.2%) 
158/204 (77.5%) 
72/119 (60.5%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
 
318.11 
197.20 
101.34 
 
< 0.001 
< 0.001 
< 0.001 
 
16.57 
25.58 
9.57 
 
11.8-23.28 
19.14-42.5 
5.94-15.43 
CL 
Combined 
Male 
Female 
 
36/114 (31.6%) 
21/63 (33.3%) 
15/51 (29.4%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
 
24.62 
17.03 
8.16 
 
< 0.001 
< 0.001 
0.004 
 
3.09 
3.72 
2.60 
 
1.95-4.91 
1.94-7.15 
1.33-5.11 
6.3 COMPARING UNAFFECTED RELATIVES TO CONTROLS 
Siblings of probands affected with CP, CLP, and CL failed to demonstrate statistically 
significant increases in otitis media compared with controls; this was true regardless of sex 
(Table 8). The largest difference was between male siblings from CL families (25%) compared 
with male controls (11.8%). The pattern of results in unaffected parents was identical to siblings, 
with no statistically significant differences regardless of cleft family group or sex (Table 9). Of 
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all cleft types, siblings and parents of the CP group demonstrated the lowest frequency of otitis 
media, with lower rates than unaffected controls.  
 
Table 8: Comparing reported occurrence of otitis media in the unaffected siblings of 
NSOC cases to controls. 
 Siblings Controls  P OR 95% CI 
CP 
Combined 
Male 
Female 
 
3/56 (5.4%) 
1/21 (4.8%) 
2/35 (5.7%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
 
2.75 
0.97 
1.83 
 
0.097 
0.325 
0.176 
 
0.38 
0.37 
0.38 
 
0.12-1.24 
0.05-2.88 
0.09-1.63 
CLP 
Combined 
Male 
Female 
 
41/273 (15.0%) 
16/127 (12.6%) 
25/146 (17.1%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
 
0.66 
0.05 
0.91 
 
0.417 
0.823 
0.340 
 
1.18 
1.07 
1.29 
 
0.79-1.78 
0.52-2.06 
0.73-2.10 
CL 
Combined 
Male 
Female 
 
15/87 (17.2%) 
12/48 (25.0%) 
3/39 (7.7%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
 
1.17 
5.78 
1.14 
 
0.279 
0.016 
0.286 
 
1.40 
2.48 
0.52 
 
0.76-2.56 
1.16-5.31 
0.15-1.76 
 
Table 9: Comparing reported occurrence of otitis media in the unaffected parents of 
NSOC cases to controls. 
 Parents Controls  P OR 95% CI 
CP 
Combined 
Male 
Female 
 
8/123 (6.5%) 
4/52 (7.7%) 
4/71 (5.6%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
 
4.09 
0.75 
3.61 
 
0.043 
0.387 
0.057 
 
0.47 
0.62 
0.37 
 
0.22-0.99 
0.21-1.85 
0.13-1.07 
CLP 
Combined 
Male 
Female 
 
61/505 (12.1%) 
15/213 (7.0%) 
46/292 (15.8%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
 
0.20 
3.02 
0.49 
 
0.655 
0.082 
0.484 
 
0.92 
0.56 
1.17 
 
0.64-1.32 
0.31-1.14 
0.75-1.81 
CL 
Combined 
Male 
Female 
 
25/183 (13.7%) 
9/77 (11.7%) 
16/106 (15.1%) 
 
77/593 (13.0%) 
29/245 (11.8%) 
48/348 (13.8%) 
 
0.06 
0.00 
0.11 
 
0.807 
1.000 
0.740 
 
1.06 
0.99 
1.11 
 
0.65-1.72 
0.44-2.19 
0.59-2.02 
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6.4 COMPARING UNAFFECTED RELATIVES TO CLEFT CASES 
Compared with affected probands, both siblings and parents from CP and CLP families 
demonstrated significantly reduced rates of otitis media (Tables 10 and 11). The differences 
between probands and their relatives in CL families were more equivocal; the rate of otitis media 
was consistently higher in affected cases, but this difference was statistically significant only for 
parents (sexes combined).  
 
Table 10: Comparing reported occurrence of otitis media in NSOC cases to their 
unaffected siblings. 
 Cases Siblings  P OR 95% CI 
CP 
Combined 
Male 
Female 
 
65/87 (74.7%) 
33/45 (73.3%) 
32/42 (79.2%) 
 
3/56 (5.4%) 
1/21 (4.8%) 
2/35 (5.7%) 
 
65.71 
26.95 
38.45 
 
< 0.001 
< 0.001 
< 0.001 
 
52.20 
55.00 
52.80 
 
14.81-183.9 
6.64-455.60 
10.72-260.0 
CLP 
Combined 
Male 
Female 
 
230/323 (71.2%) 
158/204 (77.5%) 
72/119 (60.5%) 
 
41/273 (15.0%) 
16/127 (12.6%) 
25/146 (17.1%) 
 
188.39 
132.01 
53.17 
 
< 0.001 
< 0.001 
< 0.001 
 
13.99 
23.83 
7.41 
 
9.29-21.09 
16.91-44.23 
4.21-13.06 
CL 
Combined 
Male 
Female 
 
36/114 (31.6%) 
21/63 (33.3%) 
15/51 (29.4%) 
 
15/87 (17.2%) 
12/48 (25.0%) 
3/39 (7.7%) 
 
5.36 
0.91 
6.52 
 
0.021 
0.341 
0.011 
 
2.22 
1.50 
5.00 
 
1.12-4.38 
0.65-3.46 
1.33-18.77 
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Table 11: Comparing reported occurrence of otitis media in NSOC cases to their 
unaffected parents. 
 Cases Parents  P OR 95% CI 
CP 
Combined 
Male 
Female 
 
65/87 (74.7%) 
33/45 (73.3%) 
32/42 (79.2%) 
 
8/123 (6.5%) 
4/52 (7.7%) 
4/71 (5.6%) 
 
104.54 
44.05 
60.52 
 
< 0.001 
< 0.001 
< 0.001 
 
42.47 
33.00 
53.60 
 
17.9-100.8 
9.79-111.3 
15.6-184.1 
CLP 
Combined 
Male 
Female 
 
230/323 (71.2%) 
158/204 (77.5%) 
72/119 (60.5%) 
 
61/505 (12.1%) 
15/213 (7.0%) 
46/292 (15.8%) 
 
302.17 
212.80 
82.72 
 
< 0.001 
< 0.001 
< 0.001 
 
18.00 
45.34 
8.19 
 
12.56-25.8 
33.7-84.21 
5.05-13.29 
CL 
Combined 
Male 
Female 
 
36/114 (31.6%) 
21/63 (33.3%) 
15/51 (29.4%) 
 
25/183 (13.7%) 
9/77 (11.7%) 
16/106 (15.1%) 
 
13.82 
9.64 
4.45 
 
< 0.001 
0.002 
0.035 
 
2.92 
3.78 
2.34 
 
1.64-5.20 
1.58-9.02 
1.05-5.23 
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7.0  DISCUSSION 
The goals of this study were to investigate the frequency of otitis media in unaffected relatives in 
cleft families and compare the reported rates of otitis media in affected individuals with different 
cleft types. When comparing the cleft cases and relatives across cleft types (see section 6.1) there 
was an expected higher rate of otitis media in those affected with a cleft type involving the 
secondary palate (CP, CLP) compared to those with only primary palatal involvement (CL) 
regardless of sex. However, when comparing the parents and siblings of these individuals, the 
same pattern did not hold true. When comparing unaffected siblings and parents to controls, 
there was no statistically significant increase in otitis media. Interestingly, the siblings and 
parents of the CP probands showed the smallest rate of otitis media of any group. This could be 
due to the small sample size of the CP group. The CL and CLP groups each had a higher number 
of participants in the study than the CP group, which may be skewing the results. We predicted 
that family members of those affected with clefts involving the secondary palate would have a 
higher rate of otitis media than controls. Our failure to confirm this prediction could be due to 
aspects of study design. Parents may not remember having otitis media when they were young 
and therefore did not report it. There may also be a geographical bias, individuals who lived in 
more rural areas during their childhood may have never been properly diagnosed with otitis 
media.  
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The results obtained by this study demonstrate a clear association between NSOC and 
otitis media. These findings confirm that NSOC cases have a higher rate of otitis media than 
controls, but not the near 100% rate reported by Paradise (1969). Paradise had a select group of 
patients and was doing the confirmatory testing himself. He was able to diagnose the otitis media 
in the patients enrolled in his study. In contrast, in our study otitis media was self-reported, 
which may present some biases: participants may not remember having ear infections as a young 
child, may not feel it is important to report to the researcher, or may have never been diagnosed 
but still had an ear infection. Our results show up to a 79.2% otitis media rate in the CP female 
population, where the controls were 13.8%. All cases (CP, CLP, CL) showed a significant 
increase in otitis media over our control population except in the case of the female CL 
population. 
Paradise reported that 17% of CL individuals had abnormal eardrums, compared to 20% 
of controls, suggesting that CL patients were at no greater risk for middle ear concerns than the 
general population (Paradise, 1969). Sheahan (2003) reported a 16% rate of recurrent otitis 
media in their CL population, compared to 68% and 76% reported in CP and CLP, respectively. 
However, a recent study by Deelder (2011) reported that 33% of CL probands in their sample 
had otitis media. This reported rate coincides with our study, with the combined sexes having a 
31.6% rate of otitis media over the 13% rate in the control population. These two studies are 
suggestive of a defect in the eustachian tube in at least a subset of individuals affected with CL, 
raising several important questions. It suggests that some portion of CL probands may also have 
an underlying secondary palate abnormality. As further evidence, 28-40% of CL children were 
reported to have speech and language problems requiring therapy, which is significantly higher 
than the general population (Deelder et al. 2011). This has implications for children affected with 
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CL. Parents of CL children should be advised to have otological assessment at an early age, and 
to discuss speech and language therapy with the doctors by the age of two years (Deelder et al. 
2011). Furthermore, the possible diagnostic uncertainty in cases of CL has potential implications 
for both genetic counseling and genetic studies of orofacial clefting. The presence of underlying 
secondary palate involvement in ostensibly CL children could alter recurrent risks. Further 
research into CL, palatal involvement, and otitis media should be done to better define 
recurrence risk estimation for genetic counselors. There is increasing evidence from genetic 
studies that CL and CLP are etiologically distinct defects (Harville et al. 2005; Rahimov et al. 
2008). Consequently, the incorrect assignment of subjects to CL and CLP groups can reduce the 
accuracy and power of genetic studies of orofacial clefting by mixing cleft types with potentially 
distinctive etiologies.   
7.1 LIMITATIONS 
This study is characterized by several important limitations and biases.  One limitation of was the 
relatively small sample size of some groups; in particular CP. One reason for this was that CL/P 
was the primary focus of the parent project from which this data were derived; CP subjects were 
often included out of convenience. All of the data regarding otitis media was self-reported, 
leading to several potential biases (discussed earlier). Further, in a number of cases otitis media 
had to be extrapolated from other types of data, which requires a judgment call. The researchers 
were required to choose siblings within a family for inclusion. Some families only had one child 
(the proband), while others had upwards of six children, some affected others not. The 
researcher’s bias in choosing these subjects is noted and the inclusion of multiple family 
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members in multiple cases and no family members in other cases raises the possibility that some 
other factor present in these families are influencing the otitis media identified in multiple 
members.  
7.2 FUTURE STUDIES 
Future lines of study are required before this data can be submitted to the scientific community 
for review. An expanded population of cases, controls, siblings, and parents are essential to 
determine the type of cleft most related to otitis media. An expanded protocol for future studies 
in precise questioning regarding otitis media, the number of occurrences for each individual, the 
age of each occurrence, and eustachian tube placement is required as well. Medical records may 
be required to determine the extent of otitis media in participants and their families. Research 
should combine data from the Departments of Otolaryngology and Pediatrics at Children’s 
Hospital of Pittsburgh, and the University of Pittsburgh Cleft Palate Center. Furthermore, age-of-
onset related data were partially available for this study but were excluded due to insufficient 
information and confusing answers. A future study could concentrate on the age of family 
members at the time of first otitis media occurrence to determine if there are any age effects 
across the different cleft phenotypes. This information would provide guidance for craniofacial 
teams, audiology specialists, and genetic counselors in the future in order to counsel families 
with the best information possible and give them the most accurate risk assessment of 
phenotypes in individual family members.  
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7.3 CONCLUSIONS 
In conclusion, the present study confirms that the NSOC population has a higher prevalence of 
otitis media than in the general population, but does not show a sex-effect or a higher prevalence 
in family members of those affected. Interestingly, this study does show an increase in the 
prevalence of otitis media in the CL population, which has only been shown in a select number 
of research studies and may be indicative of subtle anatomical disruptions of secondary palate 
and/or associate structures.  
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